These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2825278)

  • 1. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma.
    Kalin B; Jacobsson H
    Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278
    [No Abstract]   [Full Text] [Related]  

  • 2. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
    Rudberg U; Udén R; Ahlbäck SO
    Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial radionuclide imaging during treatment of patients with diffuse bone metastases from carcinoma of the prostate.
    Perkins AC; Hardy JG; Wastie ML; Clifford KM
    Eur J Nucl Med; 1982; 7(7):322-3. PubMed ID: 6214398
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy].
    Matsuda H; Sakashita S; Arakawa M; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantification of changes in bone scans of patients with osseous metastases of prostatic carcinoma.
    Prout GR; Griffin PP; Castronovo FP
    Adv Exp Med Biol; 1992; 324():233-43. PubMed ID: 1492620
    [No Abstract]   [Full Text] [Related]  

  • 7. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
    Otsuka N; Fukunaga M; Morita R; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A
    Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative bone scintigraphy in the survey of bone-seeking cancers.
    Grob JC; Lallot C; Methlin G; Bollack C
    Prog Clin Biol Res; 1990; 348():187-94. PubMed ID: 2385606
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of skeletal metastases in prostatic and lung cancer. Mechanisms of skeletal metastases.
    Morgan JW; Adcock KA; Donohue RE
    Urology; 1990 Jul; 36(1):31-4. PubMed ID: 2368229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
    Sundkvist GM; Ahlgren L; Lilja B; Mattsson S
    Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of prostate-specific antigen and technetium-99m HMDP bone imaging.
    Shih WJ; Wierzbinski B; Collins J; Pearson TC; Magoun S; Ryo UY
    Clin Nucl Med; 1989 Oct; 14(10):750-5. PubMed ID: 2478331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF; Wollett FC
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
    Goldenberg DM; DeLand FH
    Urol Clin North Am; 1984 May; 11(2):277-81. PubMed ID: 6328719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
    Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
    Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphic control of bone metastases of prostatic cancer treated with cytonal and cyclophosphamide].
    Grossmann J; Weiss M; Deckart H; Raatzsch H
    Radiobiol Radiother (Berl); 1988; 29(6):736-8. PubMed ID: 3253797
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].
    Ostwald E; Sabri O; Cremerius U; Jakse G; Büll U
    Nuklearmedizin; 1999; 38(7):302-5. PubMed ID: 10599071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varied presentation of urinary extravasation detected on bone imaging.
    Slavin JD; Peracha H; Spencer RP
    Clin Nucl Med; 1987 Nov; 12(11):890-1. PubMed ID: 3427864
    [No Abstract]   [Full Text] [Related]  

  • 18. Paget's disease mimicing skeletal metastases in a patient with coexisting prostatic carcinoma.
    Shih WJ; Riley C; Magoun S; Ryo UY
    Eur J Nucl Med; 1988; 14(7-8):422-3. PubMed ID: 3181194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the performance and interpretation of bone scans.
    Muroff LR
    Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
    [No Abstract]   [Full Text] [Related]  

  • 20. [Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
    Pabst HW; Langhammer H; Schmid L; Sintermann R
    Rofo; 1981 Jul; 135(1):44-9. PubMed ID: 6288532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.